Korro Bio, Inc.
KRRO
$10.18
-$0.90-8.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -113.50M | -117.26M | -88.42M | -91.36M | -87.41M |
| Total Depreciation and Amortization | 3.44M | 4.28M | 4.88M | 4.57M | 4.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.24M | 38.85M | 6.98M | 6.12M | 5.86M |
| Change in Net Operating Assets | -361.00K | -4.43M | 8.20M | 13.39M | 14.85M |
| Cash from Operations | -70.18M | -78.56M | -68.35M | -67.27M | -62.64M |
| Capital Expenditure | -420.00K | -518.00K | -1.89M | -6.59M | -12.41M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.61M | 44.51M | 28.20M | 12.73M | -72.55M |
| Cash from Investing | -21.03M | 43.99M | 26.31M | 6.14M | -84.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 88.73M | 685.00K | 1.24M | 1.84M | 69.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 88.73M | 685.00K | 1.24M | 1.84M | 69.39M |
| Foreign Exchange rate Adjustments | 39.00K | 64.00K | -15.00K | -13.00K | -4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.45M | -33.82M | -40.82M | -59.31M | -78.21M |